Half-year report · HY
2112.TEDINET S100WZFP
Period2025-04-01 → 2025-09-30
Filed2025-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥32.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥1.4bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.4bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥30.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥29.4bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥26.7bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.3bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥12.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.2bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥16.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.4bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.9bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.9bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥869m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥520m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥372m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥55.21 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥77.91 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.53 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 59.6% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-04-01 → 2025-09-30 | ¥68m |
| Otherother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥60m |
| Otherother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥8m |
| Otherother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥38m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥82m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥82m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥723m |
| Biotechnologyreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥847m |
| Biotechnologyreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥807m |
| Biotechnologyreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥39m |
| Biotechnologyreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥160m |
| Sugarreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥15.8bn |
| Sugarreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥15.8bn |
| Sugarreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥35m |
| Sugarreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥16.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥16.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥82m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥67m |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥59m |
| Otherother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥8m |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥39m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥62m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥62m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥701m |
| Biotechnologyreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥838m |
| Biotechnologyreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥799m |
| Biotechnologyreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥39m |
| Biotechnologyreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥186m |
| Sugarreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥15.3bn |
| Sugarreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥15.3bn |
| Sugarreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥14m |
| Sugarreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥62m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 498
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人日本橋事務所 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)千 保 有 之 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)新 藤 弘 一 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 16162000000 | JPY |
| Net sales (5-year summary) | InterimDuration | 16667000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 32519000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 1505000000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 1570000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 3052000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | 1055000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 1516000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 2136000000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 900000000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 1968000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 3135000000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 14384000000 | JPY |
| Net assets (5-year summary) | InterimInstant | 18203000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 16618000000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 26680000000 | JPY |
| Total assets (5-year summary) | InterimInstant | 30540000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 29405000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | 38.53 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 55.21 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 77.91 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings per share (5-year summary) | InterimDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.539 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.596 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.565 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 2005000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 1020000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 3701000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -372000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | 869000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -520000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -1147000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | -1253000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -2171000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 2789000000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 3947000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 3313000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 35000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 35000000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 35000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 35000000 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 4060000 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.1475 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |